Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 12,580.70 +125.86 1.01%
S&P 500 1,332.42 +14.60 1.11%
Nasdaq 2,870.99 +33.46 1.18%
Ticker Volume Price Price Delta
STOXX 50 2,160.31 +12.39 0.58%
FTSE 100 5,391.14 +34.80 0.65%
DAX 6,396.84 +73.65 1.16%
Ticker Volume Price Price Delta
Nikkei 8,592.08 -65.00 -0.75%
TOPIX 720.85 -6.18 -0.85%
Hang Seng 18,686.20 -369.21 -1.94%
Gold 1,549.20 -0.12%
EUR-USD 1.2468 -0.2793%
Nasdaq 2,870.99 +1.18%
DJIA 12,580.70 +1.01%
S&P 500 1,332.42 +1.11%
FTSE 100 5,391.14 +0.65%
STOXX 50 2,160.31 +0.58%
DAX 6,396.84 +1.16%
Oil (WTI) 90.38 -0.42%
U.S. 10-year 1.721% -0.024
BAC:US 7.44 +4.06%
FB:US 28.84 -9.62%
  • Exchange: OTC US
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Medical-Drugs

Tibet Pharmaceuticals Inc

Add to Portfolio

TBET:US

0.17000 USD 0.03000 15.00%

As of 20:10:00 ET on 05/29/2012.

Snapshot for Tibet Pharmaceuticals Inc (TBET)

Open: 0.19000 Day's Range: 0.15000 - 0.20000 Volume: 17,600 Bid: -
Previous Close: 0.20000 52wk Range: 0.15000 - 2.74000 1-Yr Rtn: -93.82% Ask: -

Stock Chart for TBET

No chart data available.
  • TBET:US 0.17000
  • 1D
  • 1M
  • 1Y
0.20000
Interactive TBET Chart

Previous Close

Key Statistics for TBET

Current P/E Ratio (ttm) 0.2125
Estimated P/E (-) -
Earnings Per Share () (ttm) 0.8000
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 2.52
Shares Outstanding (M) 14.85
Enterprise Value (M USD) (ttm) -
Enterprise Value/EBITDA (ttm) -
Price/Book (mrq) 0.0535
Price/Sale (ttm) 0.0681
Dividend Indicated Gross Yield 0.0000
Next Earnings Announcement -
More TBET Key Statistics mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Financials for TBET

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)
More TBET Income Statement Data
  • Total Assets
  • Total Liabilities (M/USD)
  • Debt to Assets (%)
More TBET Balance Sheet Data
  • Operating
  • Investing
  • Financing (M/USD)
More TBET Cash Flow Data

Company Profile & Key Executives for TBET

Tibet Pharmaceuticals Inc. is a pharmaceutical company which researches, develops, manufactures, and markets modernized traditional Tibetan medicines.

Sabrina Y RenChief Financial Officer
More Company Profile & Key Executives for TBET

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Advertisements